AGE   $11.1  -11.90% Market Closed

AgeX Therapeutics Inc
Total Cash 345.00K
totalCashPerShare 0.138
EBITDA -9.83M
Total Debt 4.37M
quickRatio 0.068
currentRatio 0.127
Total Revenue 142.00K
debtToEquity 81.467
Revenue/Share 0.132
ROA -0.81876
ROE
grossProfits
freeCashflow -2.01M
operatingCashflow -7.80M
earningsGrowth
revenueGrowth 6.0
grossMargins 0.71831
ebitdaMargins 0.0
operatingMargins -63.57143
profitMargins 0.0
enterpriseValue 31.67M
forwardPE
floatShares 2.45M
sharesOutstanding 2.50M
sharesShort 4.47K
sharesShortPriorMonth 4.71K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders
heldPercentInstitutions
Short Ratio help_outline 3.88%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 5.068
Price To Book help_outline 2.19
earningsQuarterlyGrowth
netIncomeToCommon -14.80M
trailingEps -482.53%
forwardEps
enterpriseToEbitda -3.22
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount
lastUpdated April 6, 2024, 4:37 p.m.